Pharmaceutical sales representatives can have great impact on patient care but until now have not always been subject to rigorous certification standards. Dr. Lyle Bootman, chairman of the Medical Representatives Certification Commission and dean of the University of Arizona College of Pharmacy, tells host Bruce Japsen about a new initiative that will prepare drug, device and other medical sales representatives to deal with the complex regulator, legal and political environment they face when selling health care products to physicians.
The Certified Sales Rep
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Pharmaceutical sales representatives can have great impact on patient care but until now have not always been subject to rigorous certification standards. Dr. Lyle Bootman, chairman of the Medical Representatives Certification Commission and dean of the University of Arizona College of Pharmacy, tells host Bruce Japsen about a new initiative that will prepare drug, device and other medical sales representatives to deal with the complex regulator, legal and political environment they face when selling health care products to physicians.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Partnering with Patients: Building Effective Communication and Support in HF Care
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?